Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$3.58 - $7.44 $538,206 - $1.12 Million
-150,337 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$3.49 - $9.2 $4.73 Million - $12.5 Million
-1,356,446 Reduced 90.02%
150,337 $675,000
Q4 2019

Feb 14, 2020

SELL
$6.27 - $11.41 $757,666 - $1.38 Million
-120,840 Reduced 7.42%
1,506,783 $13.9 Million
Q3 2019

Nov 14, 2019

SELL
$4.75 - $8.38 $727,828 - $1.28 Million
-153,227 Reduced 8.6%
1,627,623 $11.4 Million
Q2 2019

Aug 14, 2019

BUY
$6.4 - $10.94 $1.53 Million - $2.62 Million
239,780 Added 15.56%
1,780,850 $12.6 Million
Q1 2019

May 15, 2019

BUY
$6.1 - $10.3 $2.78 Million - $4.69 Million
455,172 Added 41.92%
1,541,070 $15.9 Million
Q4 2018

Feb 14, 2019

BUY
$5.84 - $11.92 $837,450 - $1.71 Million
143,399 Added 15.21%
1,085,898 $6.73 Million
Q3 2018

Nov 14, 2018

BUY
$12.43 - $29.76 $4.74 Million - $11.4 Million
381,395 Added 67.97%
942,499 $11.7 Million
Q2 2018

Aug 14, 2018

BUY
$18.75 - $28.46 $647,175 - $982,325
34,516 Added 6.55%
561,104 $15.7 Million
Q1 2018

May 15, 2018

BUY
$15.91 - $20.82 $6.45 Million - $8.44 Million
405,222 Added 333.88%
526,588 $10.5 Million
Q4 2017

Feb 12, 2018

BUY
$15.2 - $20.76 $1.84 Million - $2.52 Million
121,366
121,366 $2.29 Million

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $42.5M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.